Novel coronavirus outbreakInfectious Disease Testing Monitor: Clearstate’s latest proprietary market trackerSince its initial identification in China in December 2019, the novel coronavirus (COVID-19) outbreak has grown exponentially, affecting more than 115 countries and making a significant impact on health, trade, travel and the global economy. Clearstate has the relevant data and market insights to help key stakeholders from industry players, healthcare providers, payors and policymakers assess the potential impact of the outbreak, identify the gaps in current prevention capability and define potential solutions to better prepare for the next pandemic. Find out more
Infectious Diseases Testing Monitor A. Database providing size and share estimates for infectious diseases in 22 countries across APAC and LATAM with details on: Testing technology (immunoassays, molecular diagnostics, point-of-care, sequencing)Instruments (RT-PCR, immunoassays) vs. reagentsType of infectious disease tests (virology, respiratory, bacteriology)Share of test value by international vs. domestic suppliersOverview of molecular diagnostics lab testing capability & installation in ChinaYears: 3 year historical growth & 5-year CAGR forecast , with latest data available for 2018/19 B. Market commentary providing viewpoints on the challenges and gaps in Asia’s healthcare systems, infrastructure, delivery resources and policies in responding to the current COVID-19 outbreak. The report also takes a look at China and other Asian countries’ experiences, the innovative ways and decisive actions undertaken that can potentially be future best practices. Beyond what governments can do, the report highlights the importance of leveraging on capabilities from all key stakeholders in the healthcare ecosystem, from healthcare providers to IVD manufacturers.
Molecular Diagnostics Lab Profile (MDxPRO) Detailed testing and installation profile of 600+ individual molecular diagnostics laboratories in 10 countries in APAC and LATAM detailing: Lab throughputAnalyser installation # of unit, brands and models of analysers and year installedType of infectious diseases tested and test volumeBrands of assays usedAverage lab buying price
on-demand WebinarA special on infectious diseases in AsiaAs the virus spreads further in Asia, we invite Ivy Teh, Global Managing Director and Chee Hew, Director of Data Analytics & Consulting at EI Clearstate to share our views and answer questions. Watch webinar
INFOGRAPHICHow prepared are APAC’s MDx labs to manage the covid-19 pandemic?Covid-19 has not only impacted test volumes but also spurred changes in test practices and purchasing behaviour in APAC’s MDx labs. View infographic
ON-DEMAND WEBINARHow will the covid-19 pandemic impact the global MDx market?This webinar zooms in on two of the fastest-growing molecular testing areas: cancer and covid-19 testing to uncover the market opportunities for IVD companies. Watch webinar